EDISON EQUITY RESEARCH: EKSO BIONICS - UNAPPRECIATED UPSIDE POTENTIAL FROM INDUSTRIALS

The recent share price volatility is one of the risks of investing in early stage companies like Ekso but it should not detract from the fact that Ekso is one of the leading players in the exciting, emerging field of assistive exoskeletons. It is the only company that is targeting military, industrial and healthcare applications and the third contract secured with SOCOM on the TALOS project should illustrate the quality of its technology and engineers. Although risk will remain, there is substantial upside potential for those willing to ride out the volatility and hold in for the long term. 

Ekso Bionics is a pioneer in the field of human robotic exoskeletons that augment mobility, strength and endurance. It is development-stage company based in Richmond, California. 
 
To view our full report, please click here

Click here to view all of Edison Investment Research’s published reports


 


Ekso Bionics (NASDAQ:EKSO)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Ekso Bionics Charts.
Ekso Bionics (NASDAQ:EKSO)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Ekso Bionics Charts.